BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MAP3K1, ENSG00000095015, 4214, Q13233, MEKK1, MEKK, MAPKKK1
27 results:

  • 1. Dexamethasone activates c-Jun NH2-terminal kinase (JNK) which interacts with GR and protects it from ubiquitin-mediated degradation in NSCLC cells.
    Srivastava S; Siddiqui S; Chowdhury S; Trivedi AK
    Biochem Biophys Res Commun; 2023 Apr; 650():1-8. PubMed ID: 36764207
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancer.
    Peralta-Arrieta I; Trejo-Villegas OA; Armas-López L; Ceja-Rangel HA; Ordóñez-Luna MDC; Pineda-Villegas P; González-López MA; Ortiz-Quintero B; Mendoza-Milla C; Zatarain-Barrón ZL; Arrieta O; Zúñiga J; Ávila-Moreno F
    Eur J Cancer; 2022 Jan; 160():189-205. PubMed ID: 34844838
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. mekk1-Dependent Activation of the CRL4 Complex Is Important for DNA Damage-Induced Degradation of p21 and DDB2 and Cell Survival.
    Bacher S; Stekman H; Farah CM; Karger A; Kracht M; Schmitz ML
    Mol Cell Biol; 2021 Sep; 41(10):e0008121. PubMed ID: 34251884
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Methods for Dissecting Intersegmental Planes in Segmentectomy: A Randomized Controlled Trial.
    Chen X; Jin R; Xiang J; Han D; Zhang Y; Li C; Yang S; Wu H; Han Y; Yuan Y; Chen K; Du H; Hang J; Sihoe ADL; Li H
    Ann Thorac Surg; 2020 Jul; 110(1):258-264. PubMed ID: 32171731
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma.
    Lin G; Li C; Li PS; Fang WZ; Xu HP; Gong YH; Zhu ZF; Hu Y; Liang WH; Chu Q; Zhong WZ; Wu L; Wang HJ; Wang ZJ; Li ZM; Lin J; Guan YF; Xia XF; Yi X; Miao Q; Wu B; Jiang K; Zheng XB; Zhu WF; Zheng XL; Huang PS; Xiao WJ; Hu D; Zhang LF; Fan XR; Mok TSK; Huang C
    Ann Oncol; 2020 Apr; 31(4):517-524. PubMed ID: 32151507
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with lung cancers Driven by
    Sato H; Schoenfeld AJ; Siau E; Lu YC; Tai H; Suzawa K; Kubota D; Lui AJW; Qeriqi B; Mattar M; Offin M; Sakaguchi M; Toyooka S; Drilon A; Rosen NX; Kris MG; Solit D; De Stanchina E; Davare MA; Riely GJ; Ladanyi M; Somwar R
    Clin Cancer Res; 2020 Jun; 26(12):2932-2945. PubMed ID: 32122926
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. DIAPH3 promotes the tumorigenesis of lung adenocarcinoma.
    Xiang G; Weiwei H; Erji G; Haitao M
    Exp Cell Res; 2019 Dec; 385(1):111662. PubMed ID: 31586548
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prolonged overall survival following metastasectomy in stage IV melanoma.
    Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis.
    Yamada A; Komaki Y; Komaki F; Micic D; Zullow S; Sakuraba A
    Lancet Oncol; 2018 Jun; 19(6):758-767. PubMed ID: 29706374
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion.
    Zhou Q; Dai J; Chen T; Dada LA; Zhang X; Zhang W; DeCamp MM; Winn RA; Sznajder JI; Zhou G
    Cell Signal; 2017 Oct; 38():49-59. PubMed ID: 28652146
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project.
    Mochamat ; Cuhls H; Marinova M; Kaasa S; Stieber C; Conrad R; Radbruch L; Mücke M
    J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):25-39. PubMed ID: 27897391
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
    Goh G; Walradt T; Markarov V; Blom A; Riaz N; Doumani R; Stafstrom K; Moshiri A; Yelistratova L; Levinsohn J; Chan TA; Nghiem P; Lifton RP; Choi J
    Oncotarget; 2016 Jan; 7(3):3403-15. PubMed ID: 26655088
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Non-thermal plasma treatment altered gene expression profiling in non-small-cell lung cancer A549 cells.
    Hou J; Ma J; Yu KN; Li W; Cheng C; Bao L; Han W
    BMC Genomics; 2015 Jun; 16(1):435. PubMed ID: 26116417
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.
    Gavine PR; Wang M; Yu D; Hu E; Huang C; Xia J; Su X; Fan J; Zhang T; Ye Q; Zheng L; Zhu G; Qian Z; Luo Q; Hou YY; Ji Q
    BMC Cancer; 2015 Jun; 15():454. PubMed ID: 26040563
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Accomplices of NF-κB Lead to Radioresistance.
    Bai M; Ma X; Li X; Wang X; Mei Q; Li X; Wu Z; Han W
    Curr Protein Pept Sci; 2015; 16(4):279-94. PubMed ID: 25929862
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MIG-7 and phosphorylated prohibitin coordinately regulate lung cancer invasion/metastasis.
    Ho MY; Liang CM; Liang SM
    Oncotarget; 2015 Jan; 6(1):381-93. PubMed ID: 25575814
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Imaging metastatic cell trafficking at the cellular level in vivo with fluorescent proteins.
    Hoffman RM
    Methods Mol Biol; 2014; 1070():171-9. PubMed ID: 24092439
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clues to occult cancer in patients with ischemic stroke.
    Kim SJ; Park JH; Lee MJ; Park YG; Ahn MJ; Bang OY
    PLoS One; 2012; 7(9):e44959. PubMed ID: 22984594
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.
    Li Y; Sun Z; Cunningham JM; Aubry MC; Wampfler JA; Croghan GA; Johnson C; Wu D; Aakre JA; Molina J; Wang L; Pankratz VS; Yang P
    Clin Cancer Res; 2011 Jun; 17(11):3830-40. PubMed ID: 21636554
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Racial variation in willingness to trade financial resources for life-prolonging cancer treatment.
    Martin MY; Pisu M; Oster RA; Urmie JM; Schrag D; Huskamp HA; Lee J; Kiefe CI; Fouad MN
    Cancer; 2011 Aug; 117(15):3476-84. PubMed ID: 21523759
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.